Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juliana Candido

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Clinical Immunology|December 11, 2012
Cancer-related inflammationJuliana Candido, Thorsten Hagemann
Science Translational Medicine|October 30, 2024
Bayesian modeling for analyzing heterogeneous response in preclinical mouse tumor modelsBairu Zhang, Lukasz Magiera, Juliana Candido, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 23, 2024
A mechanistic PK/PD model of AZD0171 (anti-LIF) to support Phase II dose selectionAzar Shahraz, Mark Penney, Juliana Candido, et al.
Science Advances|October 18, 2023
CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cellsRemi Samain, Oscar Maiques, Joanne Monger, et al.
Nature Communications|March 12, 2020
Cancer associated fibroblast FAK regulates malignant cell metabolismFevzi Demircioglu, Jun Wang, Juliana Candido, et al.
Gastroenterology|October 11, 2020
Targeting DNA Damage Response and Replication Stress in Pancreatic CancerStephan B Dreyer, Rosie Upstill-Goddard, Viola Paulus-Hock, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Clinical Immunology|December 11, 2012
Cancer-related inflammationJuliana Candido, Thorsten Hagemann
Science Translational Medicine|October 30, 2024
Bayesian modeling for analyzing heterogeneous response in preclinical mouse tumor modelsBairu Zhang, Lukasz Magiera, Juliana Candido, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 23, 2024
A mechanistic PK/PD model of AZD0171 (anti-LIF) to support Phase II dose selectionAzar Shahraz, Mark Penney, Juliana Candido, et al.
Science Advances|October 18, 2023
CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cellsRemi Samain, Oscar Maiques, Joanne Monger, et al.
Nature Communications|March 12, 2020
Cancer associated fibroblast FAK regulates malignant cell metabolismFevzi Demircioglu, Jun Wang, Juliana Candido, et al.
Gastroenterology|October 11, 2020
Targeting DNA Damage Response and Replication Stress in Pancreatic CancerStephan B Dreyer, Rosie Upstill-Goddard, Viola Paulus-Hock, et al.
Pageof 1